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InterferonSimian virus 40 (SV40) large T antigen (TAg) is a multifunctional oncoprotein essential for productive viral
infection and for cellular transformation. We have used microarray analysis to examine the global changes in
cellular gene expression induced by wild-type T antigen (TAgwt) and TAg-mutants in mouse embryo
ﬁbroblasts (MEFs). The expression proﬁle of approximately 800 cellular genes was altered by TAgwt and a
truncated TAg (TAgN136), including many genes that inﬂuence cell cycle, DNA-replication, transcription,
chromatin structure and DNA repair. Unexpectedly, we found a signiﬁcant number of immune response
genes upregulated by TAgwt including many interferon-stimulated genes (ISGs) such as ISG56, OAS, Rsad2,
Iﬁ27 and Mx1. Additionally, we also observed activation of STAT1 by TAgwt. Our genetic studies using several
TAg-mutants reveal an unexplored function of TAg and indicate that the LXCXE motif and p53 binding are
required for the upregulation of ISGs.ll rights reserved.© 2010 Elsevier Inc. All rights reserved.Introduction
Simian virus 40 (SV40) is a small DNA virus that under permissive
conditions replicates in cells leading to the propagation of the viral
progeny. However, under nonpermissive conditions it is oncogenic in
animals and capable of inducing transformation of multiple cell lines
in cell culture systems. To perform these functions SV40 encodes two
major transforming proteins, the large T antigen (T antigen) and the
small t antigen (t antigen). The small t antigen targets the cellular
protein phosphatase PP2A and is required for transformation under
some conditions. On the other hand, the expression of large T antigen
alone is sufﬁcient for SV40's oncogenic potential inmost cases (Ahuja
et al., 2005).
The large T antigen (TAg) is a 708 amino acid protein that contains
several independently folding domains/regions. These domains/
regions interact with host cellular proteins and thus provide an
excellent tool to understand the different cellular processes affected
by viral infection. Three regions of TAg are essential to elicit cellular
transformation (Ahuja et al., 2005; Ali and DeCaprio, 2001). The
LXCXE motif and the J domain reside in the N-terminus of TAg, and
are involved in the inactivation of Rb family functions. The LXCXE
motif mediates binding to the Rb family members (pRb, p107 and
p130) (DeCaprio et al., 1988). The J domain, via binding to the
chaperone hsc70, stimulates the ATPase activity of hsc70, and the
resulting energy is used to release E2F from Rb (Sullivan et al., 2001).
This release leads to the upregulation of E2F transactivation activityand subsequent progression of cells into S phase. The C-terminus of
TAg is essential for inactivation of the tumor suppressor p53
(Kierstead and Tevethia, 1993; Pipas and Levine, 2001), as binding
of p53 by TAg prevents its degradation by Mdm2 and results in p53
stabilization. Therefore, high levels of p53 are found in TAg
transformed cells (Oren et al., 1981).
Infection of cells by viruses often results in a potent and dramatic
shift in the transcriptional activity of host cellular genes. These
changes reﬂect the strategies developed by both host and pathogen
to facilitate their own survival. For example, many viruses induce the
expression of host cell genes involved in DNA-replication and cell
cycle to enhance its own replication. On the other hand, the induction
of interferon (IFN) and IFN-stimulated genes (ISGs) is the hallmark of
the host response to create an antiviral state. As a countermeasure to
this response, many viruses encode proteins that interfere with the
IFN induction as well as the products of the ISGs (Randall and
Goodbourn, 2008). An understanding of the host-pathogen relation-
ship requires the study of complex biological processes which result
in altered global gene expression.
Previouslyweused amouse cDNA array consisting of ~8000 genes
to compare gene expression induced by wild-type TAg in different
systems (Cantalupo et al., 2009). Moreover, we have also reported
differential gene expression induced by wild-type TAg and mutants
in the mouse intestine (Rathi et al., 2009). These studies demon-
strated that wild-type TAg regulates a large number of known E2F-
responsive genes in both systems. Our studies in intestine showed
that these genes require the LXCXE motif and J domain to be
regulated by TAg (Rathi et al., 2009; Rathi et al., 2007). In addition, we
found sets of genes that were uniquely regulated by TAg in one
system but not in the other. For example, TAg downregulates several
203A.V. Rathi et al. / Virology 406 (2010) 202–211components of the cytochrome P450 pathway in intestine, but this
pathway is not altered by TAg in mouse embryo ﬁbroblasts (MEFs)
(Cantalupo et al., 2009; Saenz-Robles et al., 2007b). Similarly, we
noted that some immune response genes were regulated by TAg in
MEFs, but not in intestine (Cantalupo et al., 2009). However, the
limited gene coverage of the array used in these studies coupled with
a lack of accompanying genetics prevented us from discerning if
those genes were independently regulated or if they were respond-
ing to the activation of an immune response pathway. In the current
study we examine TAg's effects on gene expression in MEFs, a well
characterized cell culture system. In this case, we have used mouse
whole genome arrays to examine global changes in cellular gene
expression in MEFs induced by the presence of wild-type T antigen
(TAgwt) and TAg-mutants (Fig. 1A). The mutants used for this study
are TAgN136 (expresses the ﬁrst 136 amino acids of T antigen),
TAg3213 (mutation in the LXCXEmotif) and TAgD44N (mutation in the
J domain). The transformation potential of these mutants has been
studied in several different systems. In particular, TAgN136 is unable
to transform MEFs while TAg3213 and TAgD44N show reducedFig. 1. (A) Domain maps of SV40 TAgwt and mutants. J domain (J), Rb-protein (pRb, p130 and
(OBD), Zn domain (Zn), ATPase domain (ATPase), and host range domain (HR) are labeled
with TAg or mutants. (B) Global patterns of cellular gene expression in MEFs expressing wild
this analysis (see Materials and methods for details).efﬁciency in transformation (Hahn et al., 2002; Markovics et al.,
2005; Stubdal et al., 1997; Thompson et al., 1990). The current study
reveals an unexplored function of TAg in regulation of immune
response genes.
Results
Global patterns of cellular gene expression in MEFs expressing wild-type
or mutant T antigens
We analyzed the RNA proﬁle from two day post-conﬂuent MEFs
stably expressing wild-type or mutant T antigens. Protein levels of
the wild-type or mutant TAgs in MEFs were assessed by western blot
analysis (data not shown) and only those cloneswere selected for the
studywhichwere expressing similar levels of protein. The Affymetrix
mouse whole genome chip, which consists of 21,635 unique genes,
was used for microarray analysis. Genes showing three or more than
threefold upregulation or downregulation in comparison to normal
MEFs were selected for gross analysis of gene expression (Fig. 1B).p107) binding motif (LXCXE), nuclear localization signal (NLS), origin binding domain
on the linear representation of TAg. Grey circle represents cellular proteins interacting
-type or mutant T antigens. Genes 3 fold up or down with present call were selected for
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lates 446 genes and downregulates 558 genes in comparison to
normal MEFs. MEFs expressing a truncated TAg (TAgN136) upregu-
lated 593 genes and downregulated 512 genes. Noticeably, TAgN136
upregulated more genes than wild-type TAg. Mutation of the LXCXE
motif (TAg3213) or the J domain (TAgD44N) resulted in a signiﬁcant
reduction in the number of genes upregulated by TAgwt and TAgN136,
suggesting the importance of these domains in gene regulation.MEFs
expressing TAg3213 upregulated 119 genes and downregulated 399
genes, while MEFs expressing TAgD44N upregulated 117 genes and
downregulated 470 genes. Thus, the number of genes downregulated
by TAg was not affected signiﬁcantly by these mutations. These
results differ from our previous studies in the intestine, where nearly
all gene regulation required the TAg J domain and LXCXEmotif (Rathi
et al., 2009).
TAg regulates E2F-dependent gene expression and blocks p53-dependent
targets
The LXCXE motif and J domain are required for the complete
inactivation of Rb family members and thus for the induction of E2F
target genes (Srinivasan et al., 1997; Stubdal et al., 1997; Zalvide et
al., 1998). Our previous study has shown that mice expressing
TAgN136 in the villus enterocytes regulated the same set of E2F-target
genes as TAgwt while TAg3213 and TAgD44N did not regulate a
signiﬁcant number of genes in this system (Rathi et al., 2009).
Consistent with our studies in enterocytes (Rathi et al., 2009; Saenz-
Robles et al., 2007a) we found a profound upregulation of E2F target
genes in MEFs expressing TAgwt and TAgN136. This regulation was
signiﬁcantly reduced in MEFs expressing TAg3213 and TAgD44N
(Fig. 2). We conﬁrmed the expression levels of several E2F-target
genes (BRCA1, RRM2, DHFR, B-myb, TS and Cyclin E) by semiquan-
titative RT-PCR analysis (data not shown).
TAgwt binds to the tumor suppressor p53 and blocks p53
dependent transcription (Jiang et al., 1993; Lane and Crawford,
1979; Linzer and Levine, 1979). Consistent with the microarray data
p53 target genes were upregulated in cell lines expressing TAgN136
while these genes were not altered in MEFs expressing TAg3213,
TAgD44N, or TAgwt (Fig. 3). We conﬁrmed the expression levels of
some of the p53-target genes (Lrdd, p21, NOXA, Mdm2, Cyclin G1,
Fas, PERP, Pten and Rprm) by semiquantitative RT-PCR analysis (data
not shown). Interestingly, we also found a number of growth factors
upregulated only by TAgN136 (Fig. 4) and conﬁrmed the expression
levels of some of these genes (GD15, LIF, BMP8a, PDGF-α,
amphiregulin and proliferin) by semiquantitative RT-PCR analysis
(data not shown). To our knowledge, these genes are not known to be
regulated by p53. The basis for their regulation by TAgN136 and the
biological signiﬁcance of their expression is under investigation.Fig. 2. TAg regulates gene expression by inactivating RB family proteins. TAgwt and TA
upregulation of E2F target genes. Fold change of the speciﬁed genes were determined by m
(3213) and TAgD44N (D44N). “Normalization” represents fold change of 1 (not regulated) iTAg regulates expression of immune response genes
Many immune response genes were upregulated in MEFs stably
expressing TAgwt as well as in cell abortively infected with SV40
virions (Table 1 and Fig. 5). Many of these genes are known
interferon-stimulated genes (ISGs). The products of ISGs are induced
in response to virus infection and act on infected aswell as uninfected
cells to activate a global antiviral state (Randall and Goodbourn,
2008; Sarkar and Sen, 2004). These ISGs are upregulated both inMEFs
infected with SV40 virus as well as MEFs stably expressing TAg. We
conﬁrmed the expression levels of some of the ISGs such as Iﬁ44,
Iﬁ27, Oas2, GTPase2, Rsad2,Mx1, Oasl2, and IRF7 by semiquantitative
RT-PCR (Fig. 5A). We found upregulation of these genes by MEFs
expressing TAgwt and TAgD44N (lanes 3–4 and 9–10) but not by
TAgN136 and TAg3213 (lanes 5–6 and 7–8). We also determined the
protein levels of ISG54 in MEFs abortively infected with SV40 and
MEFs stably expressing TAg or its mutants (Fig. 5B). We found that
the basal level of expression of ISG54 in normal MEFs (lane 1) was
increased in MEFs infected with SV40 (lane 2) and MEFs stably
expressing TAgwt or TAgD44N (lanes 3 and 6). In order to conﬁrm that
induction of these immune response genes by TAg is not restricted to
MEFs, we checked the protein levels of ISG56 and IRF9 in human
ﬁbroblast (BJ cells) expressing a vector control or large TAg (BJ-LT)
(Fig. 5C). The levels of ISG56 and IRF9 were signiﬁcantly increased in
BJ-LT cells relative to BJ cells (Fig. 5C).
Interferons are not made by MEFs expressing TAg
While many IFN-stimulated genes were upregulated in TAg
expressing MEFs, the levels of IFN-α and -βmRNAs were not altered
(Fig. 6A). Next, we tested the expression levels of IFN-α2, IFN-α4 and
IFN-β in TAg expressing MEFs by semiquantitative RT-PCR analysis
(Fig. 6B). MEFs infected with Sendai virus were used as a positive
control and these cells showed a robust increase in IFN-α and -β
mRNA levels. However, there was no increase in IFN mRNA levels in
TAg expressing cells. This suggests that ISG induction is not due to the
production of IFNs.
Activation of STAT1 by SV40 TAg
Stat1 plays a major role in both IFN-α/β and IFN-γ induced
signaling pathways. Upon exposure to IFNs, Stat1 is activated by
tyrosine phosphorylation by tyrosine kinases such as JAK1 (Darnell et
al., 1994; Goodbourn et al., 2000). STAT1 is also an ISG whose
transcription is upregulated by IFNs. Stat1 mRNA levels were
increased in MEFs expressing TAg (see Table 1). To test for Stat1
activation, we analyzed the phosphorylation status of Stat1 by
western blot analysis using whole-cell extracts from MEFs stablygN136 show signiﬁcant upregulation while TAg3213 and TAgD44N show intermediate
icroarray analysis for the respective category: TAgwt (TAg), TAgN136 (N136), TAg3213
n each category.
Fig. 3. TAgN136 upregulates p53 target genes. Fold change of the speciﬁed genes were determined by microarray analysis for the respective category: TAgwt (TAg), TAgN136 (N136),
TAg3213 (3213) and TAgD44N (D44N). “Normalization” represents fold change of 1 (not regulated) in each category.
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SV40 virions (Fig. 7A). We found phosphorylation of Stat1 at Tyr701
inMEFs infected with SV40 (lane 2) as well asMEFs expressing TAgwt
(lane 3) or TAgD44N (lane 6). However, Stat1 were not phosphory-
lated in MEFs stably expressing TAgN136 (lane 4) or TAg3213 (lane 5).
In addition, the steady-state levels of Stat1 protein was increased in
MEFs infected with SV40 or stably expressing TAgwt. Stat1 was also
phosphorylated at Tyr701 in BJ cells expressing TAgwt (Fig. 7B). Thus,
T antigen-induced STAT1 phosphorylation followed the same
genetics as ISG induction.Regulation of immune response genes by TAg requires interaction
with p53
TAg directly binds to the DNA-binding surface of p53 thus
blocking its ability to bind promoters and to regulate gene expression
(Bargonetti et al., 1993; Jiang et al., 1993). As a consequence, complex
formation between TAg and p53 interferes with the expression of
p53-regulated genes involved in several biological processes such as
cell cycle (p21, cyclin G1), DNA repair (GADD45), apoptosis (Bax)
and signal transduction (IGF-BP3). We found that MEFs expressing
TAgN136, a truncation mutant unable to bind p53, did not show
induction of immune response genes (Fig. 5A). To determine if p53
binding to TAg is required for ISG regulation, we used TAg mutant
Patch-1 (Ahuja et al., 2009). Mutations comprising patch-1 specif-
ically alter the p53–TAg interface and thus fail to bind and inactivateFig. 4. Upregulation of growth factors by TAgN136. Fold change of the speciﬁed genes were
(N136), TAg3213 (3213) and TAgD44N (D44N). “Normalization” represents fold change of 1 (p53 (Ahuja et al., 2009). Fig. 8 shows that Patch-1 is defective for the
upregulation of ISGs. We conclude that T antigen binding and
perhaps stabilization of p53 is required for ISG induction.Discussion
SV40 is thought to induce transformation in part by acting on key
transcriptional regulators and thereby altering cellular gene expres-
sion. Thus, SV40 TAg antagonizes the ability of Rb-proteins to repress
E2F-dependent gene expression leading to the expression of genes
required for cell cycle entry and progression while simultaneously
blocking p53-dependent transcription and consequently inhibiting
apoptosis. Consistentwith this view, we previously reported that TAg
upregulates E2F-dependent genes in both primary MEFs and
transgenic murine enterocytes and that p53-dependent transcrip-
tion was not induced in either of these systems (7). However, these
studies were limited by the use of an Agilent mouse cDNA array
which only included 8462 genes of the estimated 21,000 mouse
genes.
We have now extended these studies by the use of mouse whole
genome arrays and by including three keymutants (TAgN136, TAg3213
and TAgD44N) in addition to TAgwt in the analysis. TAg3213 and
TAgD44N are defective for Rb protein inactivation but retain the ability
to bind p53, while TAgN136 is defective for p53 interaction but retains
the ability to inhibit the Rb proteins. In addition, to eliminate genes
whose regulation may be altered as a consequence of cell linedetermined by microarray analysis for the respective category: TAgwt (TAg), TAgN136
not regulated) in each category.
Table 1
Immune response genes regulated by SV40, TAg and mutants.
Speciﬁc function Biological process Description Entrez
gene ID
Gene symbol SV40 TAg N136 3213 D44N
Transcription Interferon type I
biosynthetic process
Interferon regulatory factor 7 54123 Irf7 29.1 4.2 1.0 0.8 5.7
Interferon dependent positive acting transcription
factor 3 gamma
16391 Irf9 3.7 2.8 0.9 0.7 2.4
JAK/Stat signaling Signal transducer and activator of transcription 1 20846 Stat1 5.8 3.1 1.5 0.5 2.0
Signal transducer and activator of transcription 2 20847 Stat2 7.5 1.9 1.0 0.5 1.5
Cytokine and
chemokine signaling
N-myc (and STAT) interactor 64685 Nmi 3.5 4.3 1.4 1.2 2.3
PML body Promyelocytic leukemia 18854 Pml 1.8 2.5 3.1 1.4 1.9
Nuclear antigen Sp100 20684 Sp100 4.5 7.2 1.1 1.1 2.2
RNA binding Interferon-induced 2′–5′ oligoadenylate synthetase 1C 114643 Oas1c 2.5 2.4 2.2 1.5 2.5
2′–5′ oligoadenylate synthetase-like 1 231655 Oasl1 16.0 2.7 1.2 1.1 3.5
2′–5′ oligoadenylate synthetase 1A 246730 Oas1a 13.8 18.9 4.0 1.3 15.1
2′–5′ oligoadenylate synthetase 2 246728 Oas2 9.5 9.1 2.1 1.2 4.2
2′–5′ oligoadenylate synthetase-like 2 23962 Oasl2 82.4 16.3 0.6 0.4 7.1
Binding to other
proteins
Interferon-induced Interferon-induced protein with tetratricopeptide
repeats 1
15957 Iﬁt1/ISG56 55.7 7.7 2.0 0.5 4.6
Interferon-induced protein with tetratricopeptide
repeats 2
15958 Iﬁt2/ISG54 4.3 2.4 1.7 0.9 2.1
Interferon-induced protein with tetratricopeptide
repeats 3
15959 Iﬁt3/ISG49 13.5 4.3 1.1 0.4 3.0
Interferon activated gene 202B 26388 Iﬁ202b 7.7 3.3 1.2 0.8 2.3
Interferon activated gene 203 15950 Iﬁ203 10.8 2.7 1.2 1.0 2.0
Interferon activated gene 204 15951 Iﬁ204 8.3 3.2 0.9 1.1 1.8
NC* Interferon-induced Interferon-induced protein 35 70110 Iﬁ35 3.6 3.1 1.8 1.0 2.1
Interferon-induced protein 44 99899 Iﬁ44 49.8 17.0 1.1 0.5 6.5
Interferon, alpha-inducible protein 27 76933 Iﬁ27 21.6 21.5 3.4 1.6 6.5
Interferon gamma inducible protein 47 15953 Iﬁ47 9.0 4.2 0.9 0.9 1.9
Helicase Interferon-induced Interferon-induced with helicase C domain 1 71586 Iﬁh1 22.6 8.9 3.0 0.6 4.7
Interferon type I
biosynthetic process
DEAD (Asp-Glu-Ala-Asp) box polypeptide 58 230073 Ddx58/RIG-I 5.5 4.2 1.2 0.9 1.6
Catalytic activity Virus response Radical S-adenosyl methionine domain containing 2 58185 Rsad2 37.9 12.4 1.5 1.2 6.7
GTPase Interferon-induced Myxovirus (inﬂuenza virus) resistance 1 17857 Mx1 11.4 4.1 1.1 0.9 1.8
Myxovirus (inﬂuenza virus) resistance 2 17858 Mx2 8.0 3.2 0.9 1.0 2.5
GTPase, very large interferon inducible 1 74558 Gvin1 3.4 2.5 1.7 0.5 1.1
Interferon inducible GTPase 1 60440 Iigp1 23.2 6.8 0.3 0.3 2.8
Interferon inducible GTPase 2 54396 Iigp2 10.1 8.5 1.0 0.6 4.4
Interferon gamma induced GTPase 16145 Igtp 15.0 8.1 1.7 0.8 4.0
Protein kinase Interferon-induced Eukaryotic translation initiation factor 2-alpha kinase 2 19106 Eif2ak2/PKR 3.1 2.3 1.1 0.9 2.0
Ubiquitin like/protein
binding
Interferon-induced Interferon, alpha-inducible protein 100038882 Isg15 33.2 9.8 1.7 0.4 4.1
Exonuclease Interferon-induced Interferon-stimulated protein 57444 Isg20 3.8 1.9 1.1 1.6 1.8
Adenosine deaminase Interferon-induced Adenosine deaminase, RNA-speciﬁc 56417 Adar 5.2 5.0 1.8 0.9 2.5
Receptor Response to
microbial infections
Toll-like receptor 3 142980 Tlr3 3.4 3.9 1.8 1.1 2.6
Cell adhesion Lectin, galactose binding, soluble 9 16859 Lgals9 3.5 3.9 0.9 1.1 2.4
Cell proliferation CD274 antigen 60533 Cd274 2.4 2.6 1.3 1.3 1.2
Interferon-induced RIKEN cDNA 5830458K16 gene 67775 Rtp4 28.3 7.4 1.6 0.4 4.3
Endopeptidase Antigen presentation Proteosome (prosome and macropain) subunit, beta
type 8 (large multifunctional peptidase 7)
16913 Psmb8 10.6 5.5 1.5 0.4 2.6
Proteosome (prosome and macropain) subunit, beta
type 9 (large multifunctional peptidase 2)
16912 Psmb9 4.1 6.3 3.6 0.6 2.4
MHC class II presentation Antigen presentation Ia-associated invariant chain 16149 Cd74 1.1 2.1 0.8 1.9 1.4
MHC class I presentation Antigen presentation Histocompatibility 2, K1, K region 14972 H2-K1 6.1 4.5 2.0 1.6 3.4
Histocompatibility 2, D region locus 1 14964 H2-D1 3.5 4.2 3.0 1.5 2.5
Histocompatibility 2, K1, K region 100044874 LOC100044874 6.9 5.2 2.0 1.8 3.9
Histocompatibility 2, T region locus 23 15040 H2-T23 5.1 3.6 3.0 0.9 2.0
Histocompatibility 2, D region locus 1 14980 H2-L 2.4 2.2 1.6 0.9 1.5
GTP binding Interferon-induced Guanylate nucleotide binding protein 2 14469 Gbp2 11.7 2.8 1.8 0.5 1.6
Macrophage activation 2 like 100702 Mpa2l 18.3 8.5 0.8 0.6 3.1
Transferase activity Protein localization Poly (ADP-ribose) polymerase family, member 9 80285 Parp9 5.3 4.0 1.2 0.5 2.3
Virus response Zinc ﬁnger CCCH type, antiviral 1 78781 Zc3hav1 3.8 2.8 1.0 1.2 2.1
Cyclic-nucleotide
phosphodiesterase activity
IFN-induced SAM domain and HD domain, 1 56045 Samhd1 2.5 2.3 1.4 1.8 2.0
dTTP biosynthesis LPS response Thymidylate kinase family LPS-inducible member 22169 Tyki 39.6 8.5 0.7 0.8 4.6
Placenta-speciﬁc 8 231507 Plac8 11.9 2.0 0.1 0.5 0.3
Phospholipid binding Defense response Lymphocyte antigen 6 complex, locus E 17069 Ly6e 3.5 2.3 1.1 1.7 1.4
Ubiquitin ligase Interferon-induced Deltex 3-like (Drosophila) 209200 Dtx3l 6.5 3.7 1.3 0.7 2.6
Peptidase Interferon-induced Ubiquitin speciﬁc peptidase 18 24110 Usp18 49.0 20.4 1.8 0.7 9.7
Protein/nucleic acid binding Interferon-induced Tripartite motif protein 34 94094 Trim34 3.4 2.2 1.2 0.8 0.9
List of selected immune response genes showing differential regulation (in fold change) by SV40, TAg and mutants compared to wild-type MEFs.
NC* = Not classiﬁed.
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Fig. 5. Upregulation of interferon-stimulated genes (ISGs) by TAg. (A) Transcript levels of ISGs were analyzed in normal MEFs and MEFs expressing TAgwt (TAg), TAgN136 (N136),
TAg3213 (3213) and TAgD44N (D44N). Two independent clones of each cell line were used for this experiment. cDNAs were reverse-transcribed from equal amounts of total RNA and
subjected to PCR using speciﬁc primers. Transcript level of alcohol dehydrogenase 5 (Adh5) was used as a loading control. (B) MEFs were infected with SV40 (lane 2) or stably
expressing TAg or its mutants (lanes 3–6) were used. Whole-cell extracts from these cells were subjected to immunoblot for ISG54. Mock (lane 1) represents normal MEFs. β-tubulin
was used as a loading control. (C)Whole-cell extracts from BJ cells (human ﬁbroblast) expressing empty vector or TAg were subjected to immunoblots for ISG56 and IRF-9. β-tubulin
was used as a loading control.
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Studies of transgenic enterocytes expressing wild-type or mutant
TAg demonstrated that nearly all TAg-dependent gene regulation in
these cells can be explained by the inactivation of the Rb proteins and
resultant upregulation of E2F-dependent gene transcription. Neither
wild-typenor themutantTAg's affected the expressionof p53-regulated
genes, consistent with the lack of p53 expression in this cell type
(Markovics et al., 2005).
In this report we examined the consequences of wild-type and
mutant TAg's in MEFs. Consistent with our studies in enterocytes we
found that TAg induction of E2F-dependent transcription depends on
both a functional J domain andRb-binding LXCXEmotif, and that the ﬁrst
136 aminoacidsof TAg, that containbothof these elements are capable of
upregulating these genes. In contrast to enterocytes, MEFs upregulated
p53-dependent genes in response to TAgN136. However, p53-dependent
genes were not induced, or in some cases were repressed, by TAgwt and
by TAg3213 and TAgD44N, each of which retains the ability to bind p53.Fig. 6. Interferon mRNAs are not increased in MEFs expressing TAg. (A) The table
represents the fold change of the interferon genes, determined by microarray analysis
in MEFs expressing TAg or infected with SV40 virions. (B) Transcript levels of Interferon
α2, α4 and β1 were analyzed in normal MEFs and MEFs expressing TAgwt (TAg). MEFs
infected with Sendai virus were used as a positive control. cDNAs were reverse-
transcribed from equal amounts of total RNA and subjected to PCR using speciﬁc
primers. Transcript level of alcohol dehydrogenase 5 (Adh5) was used as a loading
control.
Fig. 7. Activation of STAT1 by TAg. (A) MEFs infected with SV40 (lane 2) or stably
expressing TAg or its mutants were used (lanes 3–6). Whole-cell extracts from these
cells were subjected to immunoblots for phospho-speciﬁc (Tyr701) STAT1 and total
STAT1. Mock (lane 1) represents normal MEFs. β-tubulin was used as a loading control.
(B) Whole-cell extracts from BJ cells (human ﬁbroblast) expressing empty vector (BJ)
or TAg (BJ-LT) were subjected to immunoblots for phospho-speciﬁc (Tyr701) STAT1. β-
tubulin was used as a loading control.Induction of immune response genes by TAg requires the LXCXE motif
and p53 binding
Previously we noticed that TAg regulated a set of immune
response genes inMEFs and that these same genes were not regulated
by TAg in transgenic enterocytes (7). The use of the whole genomeFig. 8. Regulation of immune response genes by TAg requires interaction with p53.
Transcript levels of Interferon-stimulated genes including Oasl2, Mx1 and IRF-7 were
analyzed in normal MEFs and MEFs expressing TAgwt (TAg), TAgN136 (N136) or p53
binding defective mutant, Patch-1 (P1). cDNAs were reverse-transcribed from equal
amounts of total RNA and subjected to PCR using speciﬁc primers. Transcript level of
alcohol dehydrogenase 5 (Adh5) was used as a loading control.
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number of immune response genes by SV40 T antigen (Table 1). These
genes represent two major classes: (1) Interferon-stimulated genes
(ISGs), such as the OAS family, MX1, ISG56, ISG54, ISG15, Cig5,
GTPase, P200 gene family and PKR; and, (2) genes involved in
interferon induction and signaling such as IRF-7, IRF-9, RIG-1, STAT1
and STAT2. This collection of genes was upregulated in both MEFs
abortively infectedwith SV40 as well as inMEFs stably expressing TAg
indicating that their altered regulation is not an artifact arising from
cell line establishment.
The genetic data suggests that the immune response genes are
regulated by a common mechanism. All of these genes are regulated
by TAgwt and by TAgD44N but not by TAgN136 or TAg3213. This suggests
a requirement for both the LXCXE motif and a TAg function or
functions carboxy-terminal to amino acid 136. The inability of TAg3213
to regulate the immune response genes suggests that TAg binding to
Rb family members plays a role in this effect. However, the
inactivation of Rb proteins by TAg is thought to be J domain
dependent so the observation that TAgD44N is capable of regulating
these genes argues against this possibility. Perhaps the LXCXE motif
can also act on Rb proteins in a J domain-independent manner.
Alternatively, the LXCXE motif may target cellular proteins other than
Rb and these unknown targets may play a role in regulating the
immune response genes.
TAgN136 is fully able to inactivate Rb family members, yet it is
unable to induce ISGs. This indicates that the regulation of immune
response genes requires one or more activities residing in the
carboxy-terminal region of TAg. One candidate activity is the ability
of TAg to bind p53 and we found that a p53 binding defective mutant
of TAg (Patch-1) is unable to upregulate ISGs (Fig. 8). This indicates
that the TAg–p53 interaction is necessary for ISG induction. At present
we cannot distinguish between a “loss of function” model, in which
p53 normally functions to repress ISG induction and TAg blocks this
p53 action, or a “gain of function” model in which the TAg–p53
complex is actively involved in ISG expression. Bocchetta et al. have
shown that TAg–p53 complexes are required to activate the insulin-
like growth factor-I promoter (Bocchetta et al., 2008). Consistent with
a “gain of function” hypothesis, enterocytes, which lack p53
expression, do not show induction of immune response genes
(Cantalupo et al., 2009; Rathi et al., 2009). In either case, binding of
TAg to p53 alone is not sufﬁcient for ISG induction as TAg3213 can bind
to p53 but is unable to induce the immune response genes.
Collectively, our mutant analysis suggests cooperation between
LXCXE motif of TAg and binding with p53 in the regulation of
immune response genes.
TAg activates STAT1 in the absence of interferon production
Interestingly, TAg is capable of inducing the downstream inter-
feron pathway without affecting the levels of IFN-α or IFN-β. We
found that TAg induces STAT1 Tyr701 phosphorylation suggesting
that TAg can activate the interferon signaling pathway independent of
interferon production. One possibility is p53-dependent activation of
STAT1 by c-Abl1 tyrosine kinase instead of the classical JAK–STAT
pathway as reported by Youlyouz-Marfak et al. (2008). Furthermore,
TAg-mutants capable of inducing ISG expression also induce STAT1
phosphorylation while mutants defective for ISG induction do not
induce STAT1 phosphorylation. This suggests that the primary
mechanism by which TAg induces ISGs is through STAT1 signaling.
In conclusion, we have shown that SV40-transformed MEFs have
activated the interferon pathway in the absence of interferon
production. The biological consequences of this activation remain
unclear. However, one practical consequence of this observation is in
the common use of TAg in immortalization of MEFs obtained from
knockout mice. Our observation clearly demonstrates that this
practice should be critically evaluated while testing functionalconsequences of gene knockouts, especially in the studies involving
genes that modulate innate immune signaling pathways.
Several herpesviruses, such as Epstein–Barr virus, herpes simplex
virus, Kaposi's sarcoma-associated herpesvirus and HCMV have been
shown to activate IFN-responsive genes, such as MxA and OAS
(Browne et al., 2001; Mossman et al., 2001; Poole et al., 2002; Ruvolo
et al., 2003; Zhu et al., 1998). However, in these cases the induction
occurs in the context of a productive infection and the effects of the
ISGs are later mitigated by other viral functions. One interesting
question that arises is how TAg expressing MEFs are able to survive in
the presence of high levels of ISGs which are known to create growth
inhibitory environment. Future studies are needed to identify the
cellular target(s) on which TAg acts to elicit ISG expression and to
explore the connection between ISGs and transformation by TAg.
Materials and methods
Isolation of primaryﬁbroblasts, cell culture conditions, and establishment of
cell lines
Mouseembryoﬁbroblasts (MEFs)wereharvested from13.5-day-old
FVBembryosasdescribedpreviously (Markovics et al., 2005) andgrown
in DMEM (Mediatech, cat# 10-013-CV) supplemented with 10% heat-
inactivated fetal bovine serum (Hyclone, cat# SH30071.03), 100 U/ml
penicillin and 100 μg/ml streptomycin (Invitrogen, cat# 15140-122).
MEFs were grown at 37 °C in 5% CO2. Stable MEF cell lines were made
with pRSVB-neo plasmid that expresses a Geneticin (G418) resistance
gene and a cDNA or genomic version of the wild-type or mutant T
antigens (N136, 3213 (E107K and E108K) and 5110 (D44N)) under the
control of the Rous sarcoma virus (RSV) promoter (Srinivasan et al.,
1997). Primary cultures of MEFs were transfected with above plasmids
using Lipofectamine reagent (Invitrogen), according to the manufac-
turer's instructions. Upon selection in culture with 0.4 mg/ml of G418
(Invitrogen, cat# 11811-031), transformed colonies (foci)were selected
and individually grown and several independent cell lines were
established.
SV40 infection
For abortive SV40 infections, conﬂuent MEFs were infected with
SV40 at a multiplicity of infection 10 pfu/cell (M.O.I=10) as
described (Tremblay et al., 2001). Cells were incubated for an
additional 3 to 4 days before the cells were harvested with trypsin.
The cell pellet was washed three times with cold PBS/EDTA and
frozen at−80 °C for protein and RNA extraction.
RNA extraction
Wild-type MEFs and MEFs expressing TAgwt and TAg-mutants
were grown to conﬂuence and fed with fresh medium. After 2 days,
the cells were harvested and the cell pellets were washed with cold
PBS/EDTA three times. Two independent wild-type MEFs, three
independent MEFs expressing TAgwt and mutants were used to
prepare RNA. Three independent mock and SV40 infections were
conducted. Total RNA from transfected or infected MEFs was isolated
using the RNeasy kit according to the manufacturer's protocol
(Qiagen Inc.). Genomic DNA contamination was eliminated by
digesting the RNA with RNase-free DNase. The yield (at absorbance
A260) and purity (A260/A280 ratio) of each RNA sample were
determined by using a spectrophotometer (Eppendorf).
Microarrays
Total RNA was sent to the Genomics and Proteomics Core
Laboratories (University of Pittsburgh) for hybridization to the
Mouse 430 2.0 whole genome array (Affymetrix) which contains
Table 2
Primers used in this study.
Gene Forward (F) or reverse (R) Primer sequence (5′ to 3′) Product size (bp) Annealing temp. (°C) Extension time (s)
Adh F TGCACCACCAACTGCTTAG 152 58 30
R GATGCAGGGATGATGTTC
Iﬁ44 F GAGAGAACAGGGAATGAAGAAGGC 134 52.4 30
R CCAACAGAATTGCGATTGGTCC
Iﬁ27 F CCATAGCAGCCAAGATGATGTCTG 121 55 30
R GCATTTGTTGATGTGGAGAGTCC
Oas2 F AAAACCAACCGCTCCCAGTTCGTC 488 57.1 30
R GCAATGTCAAAGTCATCTGTGCC
GTPase2 F CTTCCACCTGCTTGTTCTTTGG 266 55.4 30
R TCACAGTTTCCTCAGTGCTGGG
Rsad2 F CAATCACACCCAGCAGCAGTTAG 209 54.4 30
R AGCGATGCCTCAGAACACAGTG
Mx1 F CAGCACCTGAAAGCCTACTACCAG 135 53.6 30
R GGTGTCCTGTAAAAGCTGAAGCATC
Oasl2 F TTACAGAACAGCCAGAGCTATACGG 548 56.1 40
R CAAGGGAGATAGATTTACGTCCACG
IRF7 F ACACCATCTACCTGGGTTTTG 243 54 60
R TTGGGATTCTGAGTCAAGGC
IFN-α2 F CATCTGCTGCTTGGAATACAACC 197 56.7 30
R GGGGCTGTGTTTCTTCTCTCTCAG
IFN-α4 F TCAATGACCTCAAAGCCTGTGTG 211 56.6 30
R CACTCCTCCTCACTCAGTCTT
IFN-β F AAGAGTTACACTGCCTTTGCCATC 138 53.2 30
R AAACACTGTCTGCTGGTGGAGTTC
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array were converted into RMA expression values using BRB-Array
Tools (Rich Simon, National Cancer Institute, http://linus.nci.nih.
gov/BRB-ArrayTools.html). An average fold change ratio (experi-
mental/control) and a one-sample T-test was calculated for each
probe set. The total number of genes which were selected showed
three fold up or downregulation in an individual experimental class
(TAgwt / TAgN136/ TAg3213/ TAgD44N). We applied additional criteria
of present and absent calls provided by Affymetrix data ﬁles. To be
included for consideration, an upregulated gene needs to be present
in all the replicates of an experimental class and a downregulated
gene needs to be present in all the replicates of the control class
(wild-type MEFs). Microarray data submitted to GEO, under the
accession number: GSE20620.
Reverse transcription PCR (RT-PCR) analysis
cDNA synthesis from 1 μg of total RNA was performed using
Superscript II Reverse Transcriptase (Invitrogen). PCR was performed
with equal amounts of cDNA using GoTAq polymerase (Promega) for
25 cycles with speciﬁc primers for the different transcripts. Ampliﬁ-
cation with primers for the alcohol dehydrogenase 5 (Adh5)
transcript was used as a normalizing control. PCR reaction products
were resolved through a 2% agarose gel in 1× TAE and stained with
GelStar (Cambrex Bio Science). The cDNA was ampliﬁed with PCR
using primers speciﬁc for each gene as shown in Table 2. To ensure
that these reactions were within the linear range of the assay, we
optimized the number of cycles required to obtain non-saturated
signals. Exponential ampliﬁcations of PCR products were obtained as
follows: 2 min at 94 °C; a series of 25 cycles at 94 °C for 30 s, variable
annealing temperatures for 30 s, and 72 °C for 30 s, and a ﬁnal
extension step of 5 min at 72 °C. The annealing temperatures and
product sizes for each gene are described in Table 2. The products
were resolved on 2% agarose gels and stained with GelStar (BioWhit-
taker Molecular Applications).
Immunoblot analysis
Lysates were prepared from 2-day post-conﬂuent cells in lysis
buffer [50 mM HEPES pH 7.9, 400 mM KCl, 0.5 mM EDTA, 0.1% NP40,
10% glycerol, 1 mM DTT, 0.5 mM Na3VO4, 0.5 mM NaF, 1 μg/mlpepstatin and a protease inhibitor tablet (Roche)] for 30 min on ice,
then centrifuging the lysate for 10 min at 4 °C. Protein concentration
was determined by Bradford assay (Bio-Rad). Appropriate dilutions
of the following primary antibodies were used: anti-STAT1 (Cell
Signaling); anti-Phospho-STAT1 (Tyr701) (Cell Signaling), anti-
ISG54 (Thermo Fischer); anti-ISG56 (a gift from Dr. Saumendra N.
Sarkar), anti-IRF-9 (C-20; Santa Cruz), anti-β-tubulin-HRP (Santa
Cruz). Goat anti-mouse A2554 and goat anti-rabbit A0545 (Sigma)
were used as secondary antibodies.
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